Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Dow
Medtronic
Argus Health
Cerilliant
Fish and Richardson
Daiichi Sankyo
Mallinckrodt

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017874

« Back to Dashboard

NDA 017874 describes TRANSDERM SCOP, which is a drug marketed by Glaxosmithkline Con and is included in one NDA. It is available from three suppliers. Additional details are available on the TRANSDERM SCOP profile page.

The generic ingredient in TRANSDERM SCOP is scopolamine. There are twenty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the scopolamine profile page.
Summary for 017874
Tradename:TRANSDERM SCOP
Applicant:Glaxosmithkline Con
Ingredient:scopolamine
Patents:0
Therapeutic Class:Antiemetics
Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 017874
Mechanism of ActionCholinergic Antagonists
Suppliers and Packaging for NDA: 017874
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874 NDA Novatris Consumer Health, Inc. 0067-4345 N 0067-4345-09
TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874 NDA Novatris Consumer Health, Inc. 0067-4345 N 0067-4345-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength1MG/72HR
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 017874

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Con TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Con TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Con TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Harvard Business School
Citi
UBS
Healthtrust
Farmers Insurance
Baxter
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.